產(chǎn)品詳情
簡(jiǎn)單介紹:
Anti-CBL2抗體產(chǎn)品質(zhì)量穩(wěn)定,實(shí)驗(yàn)效果明顯,貨期快,價(jià)格優(yōu)惠,歡迎垂詢訂購(gòu)!我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CBL2抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹:
Rabbit Anti-CBL2
Cat. Number:
Anti-CBL2抗體KL-5147R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymesAnti-CBL2抗體 required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Mar 2012]
Also known as:
C CBL; CBL C; Cas Br MAnti-CBL2抗體 (murine) ecotropic retroviral transforming sequence; Cas-Br-M (murine) ecotropic retroviral transforming sequence; Casitas B lineage lymphoma proto oncogene; Casitas B-lineage lymphoma proto-oncogene; CBL 2; cbl; CBL_HUMAN; CBL2; E3 ubiquitin protein ligase CBL; E3 ubiquitin-protein ligase CBL; Oncogene CBL2; Proto oncogene c CBL; Proto-oncogene c-CBL; RGD1561386; RING finger protein 55; RNF55; Signal transduction protein CBL.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugatedAnti-CBL2抗體 synthetic peptide derived from human C CBL.
●
Predicted Molecular Weight: 99kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must beAnti-CBL2抗體 determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must beAnti-CBL2抗體 determined by the end user.
kl320Hu01 胸腺基質(zhì)**細(xì)胞生成素(TSLP)多克隆抗體 Polyclonal Antibody to Thymic Stromal Lymphopoietin (TSLP)
kl320Mu01 胸腺基質(zhì)**細(xì)胞生成素(TSLP)多克隆抗體 Polyclonal Antibody to Thymic Stromal Lymphopoietin (TSLP)
kl320Ra01 胸腺基質(zhì)**細(xì)胞生成素(TSLP)多克隆抗體 Polyclonal Antibody to Thymic Stromal Lymphopoietin (TSLP)
kl323Hu01 鈣調(diào)磷酸酶(CaN)多克隆抗體 Polyclonal Antibody to Calcineurin (CaN)
kl323Ra01 鈣調(diào)磷酸酶(CaN)多克隆抗體 Polyclonal Antibody to Calcineurin (CaN)
kl326Hu01 神經(jīng)絲蛋白3(NEF3)多克隆抗體 Polyclonal Antibody to Neurofilament 3 (NEF3)
kl327Hu01 生長(zhǎng)關(guān)聯(lián)蛋白43(GAP43)多克隆抗體 Polyclonal Antibody to Growth Associated Protein 43 (GAP43)
kl327Mu01 生長(zhǎng)關(guān)聯(lián)蛋白43(GAP43)多克隆抗體 Polyclonal Antibody to Growth Associated Protein 43 (GAP43)
kl329Hu01 微管關(guān)聯(lián)蛋白2(MAP2)多克隆抗體 Polyclonal Antibody to Microtubule Associated Protein 2 (MAP2)
kl329Mu01 微管關(guān)聯(lián)蛋白2(MAP2)多克隆抗體 Polyclonal Antibody to Microtubule Associated Protein 2 (MAP2)
kl330Hu01 黑色素瘤關(guān)聯(lián)ME20(ME20M)多克隆抗體 Polyclonal Antibody to Melanoma Associated ME20 (ME20M)
kl331Hu01 套膜蛋白(iNV)多克隆抗體 Polyclonal Antibody to Involucrin (iNV)
kl332Hu01 鳥氨酸脫羧酶(ODC)多克隆抗體 Polyclonal Antibody to Ornithine Decarboxylase (ODC)
kl336Hu01 保護(hù)素(CD59)多克隆抗體 Polyclonal Antibody to Protectin (CD59)
kl337Hu01 彈性蛋白(ELN)多克隆抗體 Polyclonal Antibody to Elastin (ELN)
kl337Mu01 彈性蛋白(ELN)多克隆抗體 Polyclonal Antibody to Elastin (ELN)
kl337Ra01 彈性蛋白(ELN)多克隆抗體 Polyclonal Antibody to Elastin (ELN)
kl343Hu01 Bcl2關(guān)聯(lián)X蛋白(Bax)多克隆抗體 Polyclonal Antibody to Bcl2 Associated X Protein (Bax)
kl343Po01 Bcl2關(guān)聯(lián)X蛋白(Bax)多克隆抗體 Polyclonal Antibody to Bcl2 Associated X Protein (Bax)